We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-1.34%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.17B
AUM Growth
+$393M
Cap. Flow
+$459M
Cap. Flow %
39.32%
Top 10 Hldgs %
24.34%
Holding
4,355
New
842
Increased
1,505
Reduced
871
Closed
1,089

Sector Composition

Rank Sector Weight
1 Financials 6.75%
2 Industrials 5.87%
3 Consumer Discretionary 5.39%
4 Technology 4.75%
5 Healthcare 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRMD icon
3101
TORM
TRMD
$3.02B
$1K ﹤0.01%
+100
New +$763
UG icon
3102
United-Guardian
UG
$33.5M
$1K ﹤0.01%
64
+7
+12% +$128
BSIN
3103
Big Sky Industrial
BSIN
$63.3M
$1K ﹤0.01%
109
+76
+230% +$1.06K
USMC icon
3104
Principal Exchange-Traded Funds Principal US Mega-Cap ETF
USMC
$3.68B
$1K ﹤0.01%
+58
New +$1.54K
VNRX icon
3105
VolitionRx Ltd
VNRX
$9.34M
$1K ﹤0.01%
+30
New +$1.75K
WF icon
3106
Woori Financial
WF
$17.6B
$1K ﹤0.01%
13
-1,071
-99% -$48.7K
WHLR
3107
Wheeler Real Estate Investment Trust
WHLR
$412K
0
WILC icon
3108
G. Willi-Food International
WILC
$403M
$1K ﹤0.01%
+100
New +$700
WRN
3109
Western Copper and Gold
WRN
$544M
$1K ﹤0.01%
800
+300
+60% +$269
WYNN icon
3110
Wynn Resorts
WYNN
$10.6B
$1K ﹤0.01%
8
-675
-99% -$117K
YHGJ icon
3111
Yunhong Green CTI Ltd
YHGJ
$7.83M
$1K ﹤0.01%
20
+6
+43% +$270
ZDGE icon
3112
Zedge
ZDGE
$38.9M
$1K ﹤0.01%
240
ZKIN icon
3113
ZK International Group
ZKIN
$61.9M
$1K ﹤0.01%
+14
New +$829
ZVRA icon
3114
Zevra Therapeutics
ZVRA
$686M
$1K ﹤0.01%
+5
New +$483
JCTC
3115
Jewett-Cameron Trading
JCTC
$11.1M
$1K ﹤0.01%
+120
New +$885
IRD
3116
Opus Genetics
IRD
$302M
$1K ﹤0.01%
8
-70
-90% -$6.36K
PVLA
3117
Palvella Therapeutics
PVLA
$2.27B
$1K ﹤0.01%
+2
New +$1.24K
TVRD
3118
Tvardi Therapeutics
TVRD
$23.4M
$1K ﹤0.01%
+3
New +$1.46K
AUMN
3119
DELISTED
Golden Minerals Company
AUMN
$1K ﹤0.01%
60
ALPN
3120
DELISTED
Alpine Immune Sciences Inc
ALPN
$1K ﹤0.01%
96
-789
-89% -$7.8K
MRNS
3121
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1K ﹤0.01%
90
-340
-79% -$8.09K
INFI
3122
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1K ﹤0.01%
387
-1,277
-77% -$2.74K
CYAD
3123
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$1K ﹤0.01%
32
-116
-78% -$4.82K
APEN
3124
DELISTED
Apollo Endosurgery, Inc.
APEN
$1K ﹤0.01%
103
-5,054
-98% -$31.8K
AMOV
3125
DELISTED
America Movil SAB de CV
AMOV
$1K ﹤0.01%
28
-383
-93% -$6.86K

Similar funds

Tower Research Capital (TRC)'s Q1 2018 Portfolio in Review

As of Q1 2018, Tower Research Capital (TRC) held 4,355 positions worth $1.17B, up 51% from $775M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) deployed $459M of net new capital in Q1 2018, opening 842 new positions and adding to 1,505 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 717,758 shares worth $50M.

By sector, the portfolio is most concentrated in Financials at 6.7% of assets, down from 11% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $21M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2018 buy was iShares MSCI EAFE ETF: 717,758 shares worth $50M.
  • Tower Research Capital (TRC) added most to iShares MSCI Emerging Markets ETF in Q1 2018, an estimated $69.7M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $21M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2018, selling an estimated $7.94M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $1.17B portfolio in Q1 2018.
  • Tower Research Capital (TRC) opened 842 new positions and closed 1,089 in Q1 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 51% quarter-over-quarter to $1.17B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2018, filed 15 May 2018.